RT Journal Article SR Electronic T1 Limited evidence of deficits in threat and safety signal neural processing in obsessive-compulsive disorder JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.09.01.22279518 DO 10.1101/2022.09.01.22279518 A1 Luke J. Hearne A1 Michael Breakspear A1 Ben J. Harrison A1 Caitlin V. Hall A1 Hannah S. Savage A1 Conor Robinson A1 Saurabh Sonkusare A1 Emma Savage A1 Zoie Nott A1 Leo Marcus A1 Sebastien Naze A1 Bjorn Burgher A1 Andrew Zalesky A1 Luca Cocchi YR 2022 UL http://medrxiv.org/content/early/2022/09/02/2022.09.01.22279518.abstract AB Background Current behavioural treatment of obsessive-compulsive disorder (OCD) is informed by fear conditioning and involves iteratively re-evaluating previously threatening stimuli as safe. However, there is limited research investigating the neurobiological response to conditioning and reversal of threatening stimuli in individuals with OCD.Methods A clinical sample of individuals with OCD (N=45) and matched healthy controls (N=45) underwent functional Magnetic Resonance Imaging (fMRI). While in the scanner, participants completed a well-validated fear reversal task and a resting-state scan.Results We found no evidence for group differences in task-evoked brain activation or functional connectivity in OCD. Multivariate analyses encompassing all participants in the clinical and control groups suggested that subjective appraisal of threatening and safe stimuli were associated with a larger difference in brain activity than the contribution of OCD symptoms. In particular, we observed a brain-behaviour continuum whereby heightened affective appraisal was related to increased bilateral insula activation during the task (r = 0.39, pFWE = 0.001).Conclusions These findings suggest that changes in conditioned threat-related processes may not be a core neurobiological feature of OCD and encourage further research on the role of subjective experience in fear conditioning.Competing Interest StatementThe authors have declared no competing interest.Funding StatementL.J.H. was supported by the NHMRC (APP1194070). L.C was supported by the NHMRC (GNT1138711, GNT2001283). MB acknowledges the NHMRC (APP2008612).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Human Research Ethics Committee of QIMR Berghofer. Written informed consent was obtained from all participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalysis code is available on github (https://github.com/clinical-brain-networks/OCDbaseline_public). The whole brain statistical maps are available on neurovault (available after publication DOI).